期刊文献+

降钙素原在ICU中的诊断与应用 被引量:11

下载PDF
导出
作者 宋琼
机构地区 上海公利医院ICU
出处 《河北医学》 CAS 2008年第5期626-628,共3页 Hebei Medicine
  • 相关文献

参考文献17

  • 1Karzai W,Oberhoffer M,Meier Hellmann A,et al..Procalcitonin a new indicator of the systemic response to severe infections Infection[J].Crit care Med,1997,25:329-334.
  • 2Michor meisner,Procalcitonin(PCT):a new innovative infection parameter.2000.ISBN-3-13-105503-0:7-8;15-16.
  • 3Nylen ES,Whang KT,Smider TH,et al.Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis[J].Crit care med,1998,26(6):1001-1006.
  • 4Michael Iisner.Procalcition a new marker of severe infection and sepsis M[M].New York Thieme,2000.179.
  • 5Assicot M,Gendrel O,Carssin H,et al.High scrum procalcitonin concentration in pations with sepsis and infection[M].Laneet,1993.341-389.
  • 6Zeni F,Viallon A,Assicot M,et al.Procalcitonin serum concentrations and severity of sepsis[J].Clin Inter care,1994,5:89-98.
  • 7oberhoffer M,Vogelsang H,Russwurm S,et al.Outcome predicition by traditional and new markers of inflammation in patients with sepsis[J].Clin Chem Lab Med,1999,37:363-368.
  • 8Kilger E,Pichter B,Goetz AE,et al.Procalcitonin as a marker of systemic inflammation after conventional or minimally[J].
  • 9Guido A,Marios K,Ursula S,et al.Relationship between procalcitonin and sevrity of injury,sepsis organ faihure and mortality in injured patiens[J].Crit Care Med,2000,28:950-957.
  • 10Oberhoffer M,Vogelsang H,Russwum S,et al.Outcome prediction by traditional and new markers of inflammation in patiens with sepsis[J].Clin chen Lab Med,1999,37(3):363-368.

二级参考文献20

  • 1[1]Sherry R M, Cue J I, Goddard J K, et al. Interleukin-10 is associated with the development of sepsis in trauma patients[J]. Trauma, 1996, 40(4):613-617.
  • 2[2]Fassbender K, Pargger H, Muller W, et al. Interleukin-6 and acute-phase protein concentrations in surgical intensive care unit patients: dignostic signs in nosocomial infection[J]. Crit Care Med, 1993, 21(8):1175-1180.
  • 3[3]Garner J S, Jarwis W R, Emori T G, et al. CDC definitions for nosocomial infections[J]. Am J Infect Control, 1998, 16(3):128-140.
  • 4[4]Benoist J F, Mimoz O, Assicot M. Procalcitonin in severe trauma[J]. Ann Biol Clin, 1998,56(5):571-574.
  • 5[5]Meisner M, Tschaikowsky K, Hutzler A. Postoperative plasma concentrations of procalcitonin after different types of surgery[J]. Intensive Care Med, 1998,24(7):680-684.
  • 6[6]Dinarello C A. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome[J]. J Infect Dis, 1991, 163(6):1177-1184.
  • 7[7]Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection[J]. Lancet, 1993,341(8844):515-518.
  • 8Lam JS, Gupta M. Tips and tricks for the management of retained ureteral stents[ J] .J Endourol,2002,16(10) :733 - 741.
  • 9Nunes AC, Romaozinho JM, Pontes JM, et al. Risk factors for stricture development after caustic ingestion [ J ]. Hepatogastroenterology, 2002, 49(48): 1563 - 1566.
  • 10Karzai W, Oberhoffer M, Meier - Hallmann A, et al. Procalcitonin - a new indicator of the systemic response to severe infections[ J]. Infection, 1997,25(6) :329 - 334.

共引文献13

同被引文献59

引证文献11

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部